MarketBeat Instant News Alerts MarketBeat Instant News Alerts - Page 374 July 11, 2026 7:20 AM ETCandriam S.C.A. Has $116.50 Million Position in Xylem Inc. $XYLMarketBeatNYSE:XYLRead Candriam S.C.A. Has $116.50 Million Position in Xylem Inc. $XYLJuly 11, 2026 7:20 AM ETCandriam S.C.A. Has $120.46 Million Stock Position in Advanced Micro Devices, Inc. $AMDMarketBeatNASDAQ:AMDRead Candriam S.C.A. Has $120.46 Million Stock Position in Advanced Micro Devices, Inc. $AMDJuly 11, 2026 7:20 AM ETAgilent Technologies, Inc. $A Shares Acquired by Candriam S.C.A.MarketBeatNYSE:ARead Agilent Technologies, Inc. $A Shares Acquired by Candriam S.C.A.July 11, 2026 7:20 AM ETCandriam S.C.A. Raises Holdings in Amgen Inc. $AMGNMarketBeatNASDAQ:AMGNRead Candriam S.C.A. Raises Holdings in Amgen Inc. $AMGNJuly 11, 2026 7:20 AM ETRegeneron Pharmaceuticals, Inc. $REGN Shares Sold by Candriam S.C.A.MarketBeatNASDAQ:REGNRead Regeneron Pharmaceuticals, Inc. $REGN Shares Sold by Candriam S.C.A.July 11, 2026 7:20 AM ETCandriam S.C.A. Raises Holdings in Merck & Co., Inc. $MRKMarketBeatNYSE:MRKRead Candriam S.C.A. Raises Holdings in Merck & Co., Inc. $MRKJuly 11, 2026 7:20 AM ETCandriam S.C.A. Acquires 640,824 Shares of NextEra Energy, Inc. $NEEMarketBeatNYSE:NEERead Candriam S.C.A. Acquires 640,824 Shares of NextEra Energy, Inc. $NEEJuly 11, 2026 7:20 AM ETMicron Technology, Inc. $MU Shares Sold by Candriam S.C.A.MarketBeatNASDAQ:MURead Micron Technology, Inc. $MU Shares Sold by Candriam S.C.A.July 11, 2026 7:20 AM ETDrugs Made In America Acquisition (NASDAQ:DMAA) Trading Down 0.1% - Here's What HappenedMarketBeatNASDAQ:DMAARead Drugs Made In America Acquisition (NASDAQ:DMAA) Trading Down 0.1% - Here's What HappenedJuly 11, 2026 7:20 AM ETCandriam S.C.A. Acquires 56,368 Shares of Thermo Fisher Scientific Inc. $TMOMarketBeatNYSE:TMORead Candriam S.C.A. Acquires 56,368 Shares of Thermo Fisher Scientific Inc. $TMOJuly 11, 2026 7:20 AM ETVisa Inc. $V Shares Sold by Candriam S.C.A.MarketBeatNYSE:VRead Visa Inc. $V Shares Sold by Candriam S.C.A.July 11, 2026 7:20 AM ETKalaris Therapeutics (NASDAQ:KLRS) Shares Down 1.1% - Here's WhyMarketBeatNASDAQ:KLRSRead Kalaris Therapeutics (NASDAQ:KLRS) Shares Down 1.1% - Here's WhyJuly 11, 2026 7:20 AM ETCandriam S.C.A. Lowers Stake in Lam Research Corporation $LRCXMarketBeatNASDAQ:LRCXRead Candriam S.C.A. Lowers Stake in Lam Research Corporation $LRCXJuly 11, 2026 7:20 AM ETCandriam S.C.A. Purchases 125,478 Shares of Palo Alto Networks, Inc. $PANWMarketBeatNASDAQ:PANWRead Candriam S.C.A. Purchases 125,478 Shares of Palo Alto Networks, Inc. $PANWJuly 11, 2026 7:20 AM ETReposiTrak (NYSE:TRAK) Trading 0.4% Higher - Here's WhyMarketBeatNYSE:TRAKRead ReposiTrak (NYSE:TRAK) Trading 0.4% Higher - Here's WhyJuly 11, 2026 7:20 AM ETMastercard Incorporated $MA Holdings Lowered by Candriam S.C.A.MarketBeatNYSE:MARead Mastercard Incorporated $MA Holdings Lowered by Candriam S.C.A.July 11, 2026 7:20 AM ETCandriam S.C.A. Grows Stock Holdings in McKesson Corporation $MCKMarketBeatNYSE:MCKRead Candriam S.C.A. Grows Stock Holdings in McKesson Corporation $MCKJuly 11, 2026 7:20 AM ETCandriam S.C.A. Has $232.79 Million Holdings in Gilead Sciences, Inc. $GILDMarketBeatNASDAQ:GILDRead Candriam S.C.A. Has $232.79 Million Holdings in Gilead Sciences, Inc. $GILDJuly 11, 2026 7:20 AM ETCandriam S.C.A. Grows Position in AbbVie Inc. $ABBVMarketBeatNYSE:ABBVRead Candriam S.C.A. Grows Position in AbbVie Inc. $ABBVJuly 11, 2026 7:20 AM ETEli Lilly and Company $LLY is Candriam S.C.A.'s 7th Largest PositionMarketBeatNYSE:LLYRead Eli Lilly and Company $LLY is Candriam S.C.A.'s 7th Largest PositionJuly 11, 2026 7:20 AM ETChime Financial, Inc. $CHYM is Brown University's 8th Largest PositionMarketBeatNASDAQ:CHYMRead Chime Financial, Inc. $CHYM is Brown University's 8th Largest PositionJuly 11, 2026 7:20 AM ETConning Inc. Purchases Shares of 24,471 Marsh & McLennan Companies, Inc. $MRSHMarketBeatNYSE:MRSHRead Conning Inc. Purchases Shares of 24,471 Marsh & McLennan Companies, Inc. $MRSHJuly 11, 2026 7:20 AM ETOaktree Acquisition Corp. III Life Sciences (NASDAQ:OACC) Trading 0.2% Higher - What's Next?MarketBeatNASDAQ:OACCRead Oaktree Acquisition Corp. III Life Sciences (NASDAQ:OACC) Trading 0.2% Higher - What's Next?July 11, 2026 7:20 AM ETRein Therapeutics (NASDAQ:RNTX) Trading Down 1.8% - Time to Sell?MarketBeatNASDAQ:RNTXRead Rein Therapeutics (NASDAQ:RNTX) Trading Down 1.8% - Time to Sell? Featured Articles and OffersRocket Lab’s Stock Drop Comes With a Bullish TwistBy Ryan Hasson | July 10, 2026The $15 Gold Fund That Pays Up to $1,152/MonthFrom Investors Alley (Ad)AeroVironment Flies Under Wall Street’s Radar Toward a $4 Billion TargetBy Jeffrey Neal Johnson | July 10, 20263 Rare-Earth ETFs That Help Investors Balance Exposure and RiskBy Chris Markoch | July 12, 2026IQM's Nasdaq Debut Could Change the Quantum Race for D-WaveBy Nathan Reiff | July 10, 2026I Turned $57k Into $1.87MFrom Decentralized Masters (Ad)PriceSmart Stock Eyes $220 as Chile Expansion Fuels GrowthBy Thomas Hughes | July 9, 2026Amazon’s New Debt Deal Puts Its AI Spending Story on TrialBy Jeffrey Neal Johnson | July 10, 2026 Alert CategoriesAll AlertsAnalystCongressional TradesConsensusCorporate Event TranscriptStock ListDividendEarningsEarnings PreviewEarnings Transcript HighlightsEstimatesGuidanceInsider TradeLockup ExpirationMarketBeat List ArticlesOptionsPriceSEC FilingStock Split Page 374 of 386 « Most Recent‹ More Recent371372373374375376377 Earlier › Earliest » Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
